Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Greece bans export of 25 drugs after pharmacists' supply warnings

Tue, 14th Jul 2015 17:14

(Adds AstraZeneca comment)

By Lefteris Karagiannopoulos

ATHENS, July 14 (Reuters) - Greece has decided to ban theexport of 25 types of drugs, the Health Ministry said onTuesday, following warnings of possible shortages that riskedleading to a humanitarian crisis.

A ministry spokeswoman quoted the Greek drugs regulator assaying there had been a significant increase in some importedmedicines being shipped back out of the country.

"Abuses by some players in the pharmaceuticals market havebeen discovered," she told Reuters.

The regulator made the warning on re-exports during ameeting at the Health Ministry on Friday, when pharmacistscomplained they faced difficulties in securing some supplies.

The spokeswoman said the ministry would closely checkexports and re-exports over the past 15 days and file complaintsat home and abroad where there is evidence of abuse. Shedeclined to say which drugs would be included in the ban.

However, the head of the drugs wholesalers' association saidthe group had not yet been informed of the ban.

The ban was the latest move in a row over the availabilityof drugs in Greece, with pharmacists, drugmakers, wholesalersand public authorities trading blame while rights group warn ofworsening public health conditions during the economic crisis.

Difficulties over drug supplies in Greece are compounded bycapital controls which prevent companies from sending moneyabroad, imposed last month to prevent the banking system fromcollapse.

Re-exporting drugs across European borders, which allowstraders to buy products in low-cost markets and sell them whereprices are higher, is permitted under European Union free traderules.

Drugmakers have nevertheless urged a curb on re-exports toprevent shortages in Greece but wholesalers trading medicineshave denied the need for such emergency action.

The European Federation of Pharmaceutical Industries andAssociations (EFPIA), which represents 40 drug companies, calledon Tuesday for "exceptional measures" in "exceptionalcircumstances".

"A proportionate, legislative ban on exporting medicinesintended for Greek patients from Greece would be an appropriateand justifiable response to possible shortages and help to averta potential humanitarian crisis," it said in a statement.

But the head of the Hellenic Association of MedicineWholesalers, Eirini Markaki, pointed the finger at internationaldrugmakers and pharmacists. "Most of the internationalpharmaceutical companies have issued quotas on the amount ofsupplies Greek warehouses can order," Markaki told Reuters.

"We have filed official complaints to the regulator so thatmeasures are taken for this to stop," she said, adding that thecomplaints targeted AstraZeneca, Novartis andJanssen, a unit of Johnson & Johnson. Novartis deniedthat it had limited its supplies to Greece, while Janssen wasnot immediately available for comment.

ASTRAZENECA DENIAL

A spokesperson for AstraZeneca said the firm had met theregulator last week "to dispute the allegations made by theHellenic Association of Pharmaceutical Warehouses".

At that meeting, AstraZeneca said, it had "provided evidenceto demonstrate that we continue to deliver in excess of thequantities of medicines currently required in the Greek market".

Markaki denied any overall increase in re-exports bywholesalers. She said an isolated case of one warehouseexporting 700,000 units of drugs in two days at the end of Junewas under investigation, but all the warehouses combined hadexported only 179,000 items so far in July.

Demand for drugs had increased because customers were tryingto build up their supplies, fearing future shortages, she added.

The pharmaceuticals industry is owed more than 1.1 billioneuros by Greek hospitals and the state-run health insurer inunpaid bills since December but it has promised to keep supplylines open on humanitarian grounds.

Separately, Greek pharmacists will go on strike on Wednesdayto protest about plans in a deal struck between Athens and itsinternational lenders on Monday to make changes to their trade.These include allowing people without a pharmacist's degree toopen a pharmacy. (Additional reporting by Kate Kelland in London; Writing byIngrid Melander; Editing by David Stamp)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.